Alpha lipoic acid (ALA) is generally well tolerated in healthy adults, but several groups of people face real risks from taking it. These include people on blood sugar-lowering medications, those with thyroid conditions, children, and anyone undergoing certain cancer treatments. The risks range from dangerously low blood sugar to interference with critical medications.
People Taking Insulin or Diabetes Medications
ALA acts as an insulin-mimicking agent. It increases glucose uptake into cells through the same pathways that insulin and metformin use, essentially telling your cells to pull more sugar out of the bloodstream. If you’re already taking medication to lower blood sugar, adding ALA on top creates a real risk of hypoglycemia, where blood sugar drops too low.
Clinical studies in people with type 2 diabetes using doses of 600 to 800 mg per day alongside their existing medications (metformin, sulfonylureas, or insulin) generally did not show dramatic drops in long-term blood sugar markers like HbA1c. But that doesn’t mean the combination is safe for everyone. ALA shares mechanisms with metformin, activating the same energy-sensing enzyme in liver and muscle cells. The concern is less about average blood sugar over months and more about unpredictable dips on any given day, particularly in people whose blood sugar is already tightly controlled or who skip meals.
There’s also a rare but serious condition called insulin autoimmune syndrome (IAS), where the body starts producing antibodies against its own insulin. Several cases have been reported in people taking ALA. This can cause episodes of severe, unexplained low blood sugar and typically requires stopping ALA entirely.
People With Thyroid Disorders
ALA directly interferes with how your body converts the thyroid storage hormone (T4) into its active form (T3). In experimental settings, co-administering ALA with T4 suppressed the expected increase in T3 production by 56% over nine days. In longer treatment periods of 22 days, T3 levels still dropped by 22% compared to T4 alone.
This is a significant concern for anyone taking levothyroxine or similar thyroid replacement medications. If you have hypothyroidism and rely on medication to maintain normal thyroid function, ALA could undercut its effectiveness by blocking the conversion step your body depends on. The result could be a return of hypothyroid symptoms: fatigue, weight gain, brain fog, and cold sensitivity, even while technically taking the correct dose of thyroid medication. People with any thyroid disorder, whether overactive or underactive, should be cautious.
Children and Adolescents
No safe dose of ALA has been established for children. While the supplement has a wide and well-documented safety range in adults, pediatric data is almost nonexistent, and the handful of case reports that do exist paint a troubling picture.
Five reported cases of ALA toxicity in children and adolescents show a pattern of seizures, lethargy, vomiting, involuntary movements, and in some cases, multi-organ failure. One 14-year-old girl died after ingesting 6 grams. A 16-year-old developed seizures and blood clotting problems after taking roughly 30 mg per kilogram of body weight, the lowest toxic dose reported in the pediatric literature. Symptoms appeared within two to four hours in most cases, and the seizures were frequently resistant to standard anti-seizure medications.
What’s notable is that the toxic threshold in children appears to be far lower and less predictable than in adults. A 42-year-old woman who took the same 6-gram dose also died from multi-organ failure, yet other adults have survived doses of 6 grams and even 18 grams. The inconsistency makes it impossible to identify a safe pediatric dose, which is why ALA supplements should be kept away from children entirely.
People Undergoing Chemotherapy
ALA is a potent antioxidant, and that’s precisely the problem during cancer treatment. Many chemotherapy drugs work by generating oxidative stress inside cancer cells, essentially damaging them faster than they can repair. An antioxidant like ALA can counteract that mechanism.
Research has directly demonstrated this effect. In melanoma cells treated with the chemotherapy drug bortezomib, adding ALA reduced the drug’s ability to stop cancer cell growth. The concern extends beyond bortezomib to other chemotherapy agents that rely on oxidative damage, including cisplatin and paclitaxel. While ALA is sometimes discussed as a way to reduce chemotherapy-induced nerve damage (a common and painful side effect), its antioxidant properties risk protecting the tumor cells right alongside the nerve cells. This trade-off makes ALA a poor choice during active cancer treatment unless specifically approved by an oncologist.
People With Thiamine (Vitamin B1) Deficiency
ALA can lower thiamine levels in the body. Thiamine is essential for energy metabolism and nerve function, and people who are already deficient face compounded risks if they start taking ALA. Groups most vulnerable to thiamine deficiency include people with alcohol use disorder, those who have had bariatric surgery, people with chronic digestive conditions that impair nutrient absorption, and anyone on a severely restricted diet.
Symptoms of worsening thiamine deficiency include confusion, difficulty with coordination, numbness or tingling in the hands and feet, and in severe cases, a dangerous condition affecting the brain and heart. If you fall into a high-risk group for B1 deficiency, taking ALA without first correcting that deficiency could accelerate the problem.
Pregnant and Breastfeeding Women
The picture here is more nuanced than a blanket prohibition. One retrospective study of pregnant women who took ALA found reassuring safety outcomes, and some regulatory bodies have not set upper intake limits for the supplement. However, no large, controlled trials have verified its safety during pregnancy, and there is essentially no data on whether ALA passes into breast milk or affects nursing infants.
The current reality is that ALA during pregnancy falls into a gray zone: not proven dangerous, but not proven safe either. Most prenatal guidance errs on the side of avoidance unless there is a specific medical reason to take it, supervised by a provider who can weigh the limited evidence.
Acute Overdose Risks for Anyone
Even in otherwise healthy adults, ALA in large quantities is toxic. The symptoms of acute overdose include seizures that resist standard treatment, severe metabolic acidosis (a dangerous shift in blood pH), breakdown of muscle tissue, kidney injury, blood clotting problems, and cardiac rhythm disturbances. Reported fatal doses start at around 6 grams (roughly ten 600 mg tablets), though some adults have survived similar or higher amounts. There is no known antidote for ALA poisoning, making treatment purely supportive.
Standard supplemental doses for adults typically range from 300 to 600 mg per day. The gap between a therapeutic dose and a potentially fatal one is large enough to be safe under normal use, but it underscores the importance of keeping supplements stored securely, especially in households with children.